Risk-based quality management (RBQM) continues to gain traction across clinical development, yet adoption remains uneven and many organizations still struggle to realize its full value. In practice, the challenge is often not whether RBQM components are being used, but whether they are implemented as part of a cohesive, cross-functional strategy that improves data quality, patient safety, and operational efficiency.
This white paper explores how organizations can build more sustainable RBQM frameworks by connecting risk assessment, central monitoring, KRIs, and study execution into an integrated model. It also examines why central monitoring is becoming an increasingly important capability across studies of all sizes, with real-world evidence showing its value in earlier issue detection, more targeted onsite monitoring, and stronger follow-through on risk signals.
What’s Inside
This white paper explores key considerations for strengthening RBQM approaches, including:
- The current state of RBQM adoption and why implementation still varies across organizations
- How to build a sustainable, enterprise-level RBQM strategy rather than deploying disconnected components
- The evolving role of central monitoring in improving data quality, patient safety, and resource efficiency
- How integrated, cross-functional processes make RBQM findings more actionable
- A real-world Phase II case study showing how central monitoring identified issues across PK collection, adverse event reporting, protocol deviations, investigational product dosing, and eligibility documentation
- Practical recommendations for improving documentation, follow-through, and site-level action once risk signals are identified
Download the White Paper
